Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Immuron Submits IND Application To FDA For Travelan

Immuron Submits IND Application To FDA For Travelan

Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA) Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA Clinical Trial to examine a

byBenzinga Newsdesk

December 5, 2022

1 minute read

Investigational New Drug (IND) application submitted to the U.S. Food and Drug administration (FDA)
Plans in place to initiate a Human clinical trial in 60 healthy volunteers in the USA
Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military
- Infectious diarrhea is the most common illness reported by travelers